title: HaloTag as a reporter gene: positron emission tomography imaging with (64)Cu-labeled second generation HaloTag ligands.
abstract: THE GOAL OF THIS STUDY IS TO EMPLOY THE HALOTAG TECHNOLOGY FOR POSITRON EMISSION TOMOGRAPHY (PET), WHICH INVOLVES TWO COMPONENTS: the HaloTag protein (a modified hydrolase which covalently binds to synthetic ligands) and HaloTag ligands (HTLs). 4T1 murine breast cancer cells were stably transfected to express HaloTag protein on the surface (termed as 4T1-HaloTag-ECS, ECS denotes extracellular surface). Two new HTLs were synthesized and termed NOTA-HTL2G-S and NOTA-HTL2G-L (2G indicates second generation, S stands for short, L stands for long, NOTA denotes 1,4,7-triazacyclononane-N,N'N''-triacetic acid). Microscopy studies confirmed surface expression of HaloTag in 4T1-HaloTag-ECS cells, which specifically bind NOTA-HTL2G-S/L. Uptake of (64)Cu-NOTA-HTL2G-L in 4T1-HaloTag-ECS tumors (4.3 ± 0.5, 4.1± 0.2, 4.0 ± 0.2, 2.3 ± 0.1, and 2.2 ± 0.1 %ID/g at 0.5, 3, 6, 18, and 24 h post-injection respectively; n = 4) was significantly higher than that in the 4T1 tumors (3.0 ± 0.3, 3.0± 0.1, 3.0 ± 0.2, 2.0 ± 0.4, and 2.4 ± 0.3 %ID/g at 0.5, 3, 6, 18, and 24 h post-injection respectively; n = 4) at early time points. In comparison, (64)Cu-NOTA-HTL2G-S did not demonstrate significant uptake in either 4T1-HaloTag-ECS or 4T1 tumors. Blocking studies and autoradiography of tumor lysates confirmed that (64)Cu-NOTA-HTL2G-L binds specifically to HaloTag protein in the 4T1-HaloTag-ECS tumors, corroborated by histology. HaloTag protein-specific targeting and PET imaging in vivo with (64)Cu-NOTA-HTL2G-L serves as a proof-of-principle for future non-invasive and sensitive tracking of HaloTag-transfected cells with PET, as well as many other studies of gene/protein/cell function in vivo.
authors: Department of Radiology, University of Wisconsin - Madison Madison, WI, USA.
authors: Hao
authors: H
authors: Hong
authors: Hélène A
authors: HA
authors: Benink
authors: H Tetsuo
authors: HT
authors: Uyeda
authors: Hector F
authors: HF
authors: Valdovinos
authors: Yin
authors: Y
authors: Zhang
authors: Poncho
authors: P
authors: Meisenheimer
authors: Todd E
authors: TE
authors: Barnhart
authors: Frank
authors: F
authors: Fan
authors: Weibo
authors: W
authors: Cai
keywords: 64Cu; HaloTag; cancer; molecular imaging; positron emission tomography (PET); reporter gene
references: Curr Top Med Chem. 2010;10(12):1237-48
references: 20388105
references: ACS Nano. 2012 Dec 21;6(12):11080-7
references: 23181687
references: Methods Mol Biol. 2008;421:191-209
references: 18826056
references: BMC Cell Biol. 2008 Apr 02;9:17
references: 18384686
references: J Nucl Med. 2008 Jun;49 Suppl 2:164S-79S
references: 18523072
references: Am J Transl Res. 2012;4(3):333-46
references: 22937210
references: Am J Nucl Med Mol Imaging. 2011 Aug 1;1(1):18-28
references: 21841970
references: Am J Nucl Med Mol Imaging. 2012;2(1):55-76
references: 23133802
references: ACS Chem Biol. 2011 May 20;6(5):401-6
references: 21226520
references: Angew Chem Int Ed Engl. 2006 Jul 24;45(30):4936-40
references: 16807952
references: BMC Genomics. 2009 Oct 27;10:497
references: 19860899
references: Am J Nucl Med Mol Imaging. 2012;2(1):33-47
references: 23133801
references: Nat Clin Pract Oncol. 2009 Jan;6(1):53-8
references: 19015650
references: Am J Nucl Med Mol Imaging. 2012 Jul 10;2(3):273-306
references: 22943038
references: Nat Rev Cancer. 2002 Sep;2(9):683-93
references: 12209157
references: Cancer Res. 2007 Apr 1;67(7):3085-93
references: 17409415
references: Lancet. 2001 Sep 1;358(9283):727-9
references: 11551583
references: Biophys J. 2009 Jan;96(1):L01-3
references: 19134467
references: Protein Expr Purif. 2011 Apr;76(2):154-64
references: 21129486
references: J Nucl Med. 2008 Dec;49(12):1905-8
references: 18997049
references: ACS Chem Biol. 2008 Jun 20;3(6):373-82
references: 18533659
references: Am J Nucl Med Mol Imaging. 2012;2(4):458-74
references: 23145362
references: Methods Mol Biol. 2007;356:195-208
references: 16988404
references: Am J Nucl Med Mol Imaging. 2011;1(1):76-79
references: 22022661
references: Curr Pharm Biotechnol. 2010 Sep 1;11(6):685-92
references: 20497109
references: Physiol Rev. 2012 Apr;92(2):897-965
references: 22535898
references: Langmuir. 2010 Jul 6;26(13):10433-6
references: 20527958
references: Methods Mol Biol. 2009;577:121-31
references: 19718513
references: Am J Nucl Med Mol Imaging. 2012;2(2):174-220
references: 23133812
references: Am J Nucl Med Mol Imaging. 2012 Jan 1;2(1):1-13
references: 22229128
references: Curr Chem Genomics. 2012;6:72-8
references: 23213345
references: Bioconjug Chem. 2009 Jul;20(7):1367-74
references: 19514716
references: Science. 2006 Apr 14;312(5771):217-24
references: 16614209
references: Annu Rev Biomed Eng. 2002;4:235-60
references: 12117758
references: J Biochem. 2011 May;149(5):609-18
references: 21278155
references: Am J Transl Res. 2011 Aug 15;3(4):392-403
references: 21904659
references: Handb Exp Pharmacol. 2008;(185 Pt 2):277-303
references: 18626607
references: Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1335-43
references: 21373764
references: Am J Nucl Med Mol Imaging. 2012;2(4):432-47
references: 23145360